CFO Yair Malca said the company believes a multi-year downturn in demand is beginning to stabilize, with management expecting ...

InMode Ltd. INMD shares are up during Friday’s premarket session after the company announced a new share repurchase program. InMode Authorizes 10% Share Buyback InMode’s Board of Directors has ...

InMode (NASDAQ: INMD) is a medical device company that provides its consumers with a wide range of treatments to help with contouring skin, treating acne, removing hair, and other aesthetic issues.

On March 13, 2026, InMode Ltd. announced that its Board of Directors approved a share repurchase program for up to 6,380,000 shares, or 10% of its outstanding stock, to be funded with existing cash.

Let's talk about what we know about cosmetic surgery. First, it's costly. It's invasive, leaves scars, and has long recovery times. Cosmetic surgery is mostly for the rich and famous -- not regular ...

InMode shares rose sharply in anticipation of the company's second-quarter earnings report. Soaring sales of medical devices used for minimally invasive cosmetic procedures drove profits 25% higher ...

InMode Ltd. is a company in the medical aesthetics space known for their cutting-edge, minimally invasive technologies (a description of each product they offer is in the analysis). The company's ...

YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

The MarketWatch News Department was not involved in the creation of this content. YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative ...

YOKNEAM, Israel, Feb. 2, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today issued the following statement ...

InMode ( (INMD)) has issued an announcement. On February 23, 2026, InMode Ltd. announced that an independent transaction committee of its board has completed a comprehensive review of proposals ...